48 resultados para Chiral
Resumo:
The use of biocatalysts in synthetic chemistry is a conventional methodology for preparing enantiomerically enriched compounds. Despite this fact, the number of experiments in chemical teaching laboratories that demonstrate the potential of enzymes in synthetic organic chemistry is limited. We describe a laboratory experiment in which students synthesized a chiral secondary alcohol that can be used in the preparation of antidepressant drugs. This experiment was conducted by individual students as part of a Drug Synthesis course held at the Pharmacy Faculty, Lisbon University. This laboratory experiment requires six laboratory periods, each lasting four hours. During the first four laboratory periods, students synthesized and characterized a racemic ester using nuclear magnetic resonance spectroscopy and gas chromatography. During the last two laboratory periods, they performed enzymatic hydrolysis resolution of the racemic ester using Candida antarctica lipase B to yield enantiomerically enriched secondary alcohol. Students successfully prepared the racemic ester with a 70%-81% overall yield in three steps. The enzymatic hydrolysis afforded (R)- secondary alcohol with good enantioselectivity (90%-95%) and reasonable yields (10%-19%). In these experiments, students were exposed to theoretical and practical concepts of aromatic acylation, ketone reduction, esterification, and enzymatic hydrolysis.
Resumo:
Condensation reactions of glycerol with aldehydes and ketones were performed under thermal heating and microwave irradiation regimes. Homogeneous and heterogeneous catalysts were tested in both conditions. A silica sulfated (SiO2-SO3H) heterogeneous catalyst demonstrated the best performance relative to a selectivity of >95% in favor of 5-membered ketals. For acetals, preference in favor of 5-membered or 6-membered functional groups depends on the nature of the catalyst. Homogenous catalysts favor the more stable 6-membered acetals, whereas heterogeneous catalysts favor the less stable 5-membered acetals. However, the isomer ratios in the acetalization reaction are too low, and hence the reaction cannot be used in a synthetic plan for functional materials. Ketalization processes mediated by SiO2-SO3H show a high selectivity in favor of a 5-membered ring (1,3-dioxolane). The scope of condensation was tested with different ketones. A mechanism for heterogeneous catalysis related to the selectivity in the cyclization process is presented herein. Solketal, a commercial product, was also obtained by a condensation reaction of glycerol and propanone, and showed a high selectivity in favor of 1,3-dioxolane. It was transformed to potential allylic and chiral intermediates. A mesogenic core was connected to the organic framework of glycerol to produce a monomer liquid crystal material with a stable smectic-C mesophase.
Resumo:
The present study investigates the isoform(s) of cytochrome P450 (CYP) involved in the metabolism of albendazole sulfoxide (ASOX) to albendazole sulfone (ASON) in patients with neurocysticercosis using antipyrine as a multifunctional marker drug. The study was conducted on 11 patients with neurocysticercosis treated with a multiple dose regimen of albendazole for 8 days (5 mg/kg every 8 h). On the 5th day of albendazole treatment, 500 mg antipyrine was administered po. Blood and urine samples were collected up to 72 h after antipyrine administration. Plasma concentrations of (+)-ASOX, (-)-ASOX and ASON were determined by HPLC using a chiral phase column and detection by fluorescence. The apparent clearance (CL/f) of ASON and of the (+) and (-)-ASOX enantiomers were calculated and compared to total antipyrine clearance (CL T) and the clearance for the production of the three major antipyrine metabolites (CLm). A correlation (P<=0.05) was obtained only between the CL T of antipyrine and the CL/f of ASON (r = 0.67). The existence of a correlation suggests the involvement of CYP isoforms common to the metabolism of antipyrine and of ASOX to ASON. Since the CL T of antipyrine is a general measure of CYP enzymes but with a slight to moderate weight toward CYP1A2, we suggest the involvement of this enzyme in ASOX to ASON metabolism in man. The study supports the establishment of a specific marker drug of CYP1A2 in the study of the in vivo metabolism of ASOX to ASON.